Moreover, HOTTIP modulates cancer stem cell properties by binding WDR5 and activating HOXA9, which enhances the Wnt/β-catenin pathway in prostate cancer stem cells [40]. The gene discussed is HOXA9; the disease is Familial prostate cancer.